Assignee
IMPAX LABORATORIES LLC
US·14 granted patents·1 pending application·143 citations·filing 2019–2025
Top patents by PatentIndex Score
15 records- 0198US11666538B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2022·Granted Jun 6, 2023·16 cites·21 claims
- 0298US11622941B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2021·Granted Apr 11, 2023·16 cites·29 claims
- 0398US11357733B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2021·Granted Jun 14, 2022·20 cites·40 claims
- 0498US10987313B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2019·Granted Apr 27, 2021·29 cites·44 claims
- 0598US10973769B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2020·Granted Apr 13, 2021·28 cites·27 claims
- 0697US10688058B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2019·Granted Jun 23, 2020·32 cites·22 claims
- 0797US2026053749A1Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2025·Application pending·0 cites
- 0896US12178919B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Dec 31, 2024·1 cites·23 claims
- 0995US12064521B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2023·Granted Aug 20, 2024·1 cites·20 claims
- 1093US12403099B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Sep 2, 2025·0 cites·19 claims
- 1193US12303605B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted May 20, 2025·0 cites·26 claims
- 1293US12274793B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Apr 15, 2025·0 cites·22 claims
- 1392US12178918B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Dec 31, 2024·0 cites·21 claims
- 1492US12128141B1Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Oct 29, 2024·0 cites·18 claims
- 1591US12491164B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2025·Granted Dec 9, 2025·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when IMPAX LABORATORIES LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →